Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales
February 01, 2024 at 06:31 AM EST
Merck still posted a quarterly loss due to previously announced charges associated with its cancer drug collaboration deal with Daiichi Sankyo.
